172 related articles for article (PubMed ID: 32534214)
1. GC-MS based comparative metabolomic analysis of MCF-7 and MDA-MB-231 cancer cells treated with Tamoxifen and/or Paclitaxel.
Semreen MH; Alniss H; Cacciatore S; El-Awady R; Mousa M; Almehdi AM; El-Huneidi W; Zerbini L; Soares NC
J Proteomics; 2020 Aug; 225():103875. PubMed ID: 32534214
[TBL] [Abstract][Full Text] [Related]
2. Untargeted Metabolomics of Breast Cancer Cells MCF-7 and SkBr3 Treated With Tamoxifen/Trastuzumab.
Sharaf BM; Giddey AD; Alniss H; Al-Hroub HM; El-Awady R; Mousa M; Almehdi A; Soares NC; Semreen MH
Cancer Genomics Proteomics; 2022; 19(1):79-93. PubMed ID: 34949661
[TBL] [Abstract][Full Text] [Related]
3. Rationale for sequential tamoxifen and anticancer drugs in adjuvant setting for patients with node- and receptor-positive breast cancer.
Kim R; Tanabe K; Emi M; Uchida Y; Osaki A; Toge T
Int J Oncol; 2005 Apr; 26(4):1025-31. PubMed ID: 15753998
[TBL] [Abstract][Full Text] [Related]
4. Evaluation Fucoidan Extracts From Undaria pinnatifida and Fucus vesiculosus in Combination With Anticancer Drugs in Human Cancer Orthotopic Mouse Models.
Burney M; Mathew L; Gaikwad A; Nugent EK; Gonzalez AO; Smith JA
Integr Cancer Ther; 2018 Sep; 17(3):755-761. PubMed ID: 29156992
[TBL] [Abstract][Full Text] [Related]
5. Metabolomics reveals the effect of valproic acid on MCF-7 and MDA-MB-231 cells.
Zhou X; Li Z; Wang X; Jiang G; Shan C; Liu S
Xenobiotica; 2020 Mar; 50(3):252-260. PubMed ID: 31092106
[TBL] [Abstract][Full Text] [Related]
6. Anti-proliferative and cytotoxic activities of Allium autumnale P. H. Davis (Amaryllidaceae) on human breast cancer cell lines MCF-7 and MDA-MB-231.
Isbilen O; Rizaner N; Volkan E
BMC Complement Altern Med; 2018 Jan; 18(1):30. PubMed ID: 29370794
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic, anti-proliferative and apoptotic effects of noscapine on human estrogen receptor positive (MCF-7) and negative (MDA-MB-231) breast cancer cell lines.
Kocak C; Kocak FE; Ozturk B; Tekin G; Vatansev H
Bratisl Lek Listy; 2020; 121(1):43-50. PubMed ID: 31950839
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin fails to interfere with the antiproliferative and cytotoxic effects of antitumor drugs.
Gewirtz DA; Di X; Walker TD; Sawyer ST
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2232-8. PubMed ID: 16609039
[TBL] [Abstract][Full Text] [Related]
9. Untargeted LC-MS/MS Metabolomics Study of HO-AAVPA and VPA on Breast Cancer Cell Lines.
Estrada-Pérez AR; García-Vázquez JB; Mendoza-Figueroa HL; Rosales-Hernández MC; Fernández-Pomares C; Correa-Basurto J
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833990
[TBL] [Abstract][Full Text] [Related]
10. The Impact of Soy Isoflavones on MCF-7 and MDA-MB-231 Breast Cancer Cells Using a Global Metabolomic Approach.
Uifălean A; Schneider S; Gierok P; Ionescu C; Iuga CA; Lalk M
Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27589739
[TBL] [Abstract][Full Text] [Related]
11. Dual in vitro invasion/migration suppressing and tamoxifen response modulating effects of a recombinant anti-ALCAM scFv on breast cancer cells.
Darvishi B; Salehi M; Boroumandieh S; Majidzadeh-A K; Jalili N; Moradi-Kalbolandi S; Farahmand L
Cell Biochem Funct; 2020 Jul; 38(5):651-659. PubMed ID: 32196701
[TBL] [Abstract][Full Text] [Related]
12. Inositol hexaphosphate (IP6) enhances the anti-proliferative effects of adriamycin and tamoxifen in breast cancer.
Tantivejkul K; Vucenik I; Eiseman J; Shamsuddin AM
Breast Cancer Res Treat; 2003 Jun; 79(3):301-12. PubMed ID: 12846414
[TBL] [Abstract][Full Text] [Related]
13. Metabolomic analysis of resveratrol-induced effects in the human breast cancer cell lines MCF-7 and MDA-MB-231.
Jäger W; Gruber A; Giessrigl B; Krupitza G; Szekeres T; Sonntag D
OMICS; 2011; 15(1-2):9-14. PubMed ID: 21241168
[TBL] [Abstract][Full Text] [Related]
14.
AlMalki RH; Sebaa R; Al-Ansari MM; Al-Alwan M; Alwehaibi MA; Rahman AMA
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835626
[TBL] [Abstract][Full Text] [Related]
15. In-vitro Evaluation of Isatin Derivatives as Potent Anti-Breast Cancer Agents against MCF-7, MDA MB 231, MDA-MB 435 and MDA-MB 468 Breast Cancers Cell Lines: A Review.
Chauhan G; Pathak DP; Ali F; Dubey P; Khasimbi S
Anticancer Agents Med Chem; 2022; 22(10):1883-1896. PubMed ID: 34477529
[TBL] [Abstract][Full Text] [Related]
16. Tamoxifen resistance and metastasis of human breast cancer cells were mediated by the membrane-associated estrogen receptor ER-α36 signaling in vitro.
Gu W; Dong N; Wang P; Shi C; Yang J; Wang J
Cell Biol Toxicol; 2017 Apr; 33(2):183-195. PubMed ID: 27837347
[TBL] [Abstract][Full Text] [Related]
17. beta-Sitosterol enhances tamoxifen effectiveness on breast cancer cells by affecting ceramide metabolism.
Awad AB; Barta SL; Fink CS; Bradford PG
Mol Nutr Food Res; 2008 Apr; 52(4):419-26. PubMed ID: 18338406
[TBL] [Abstract][Full Text] [Related]
18. Mass spectroscopy-based proteomics and metabolomics analysis of triple-positive breast cancer cells treated with tamoxifen and/or trastuzumab.
Sharaf BM; Giddey AD; Al-Hroub HM; Menon V; Okendo J; El-Awady R; Mousa M; Almehdi A; Semreen MH; Soares NC
Cancer Chemother Pharmacol; 2022 Dec; 90(6):467-488. PubMed ID: 36264351
[TBL] [Abstract][Full Text] [Related]
19. Effects of long noncoding RNA-ROR on tamoxifen resistance of breast cancer cells by regulating microRNA-205.
Zhang HY; Liang F; Zhang JW; Wang F; Wang L; Kang XG
Cancer Chemother Pharmacol; 2017 Feb; 79(2):327-337. PubMed ID: 28063065
[TBL] [Abstract][Full Text] [Related]
20. Cellular uptake mechanism and comparative evaluation of antineoplastic effects of paclitaxel-cholesterol lipid emulsion on triple-negative and non-triple-negative breast cancer cell lines.
Ye J; Xia X; Dong W; Hao H; Meng L; Yang Y; Wang R; Lyu Y; Liu Y
Int J Nanomedicine; 2016; 11():4125-40. PubMed ID: 27601899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
